Estetrol: From Preclinical to Clinical Pharmacology and Advances in the Understanding of the Molecular Mechanism of Action
Abstract Estetrol (E4) is the most recently described natural estrogen. It is produced by the human fetal liver during pregnancy and its physiological function remains unclear. E4 is the estrogenic component of a recently approved combined oral contraceptive. It is also in development for use as men...
Main Authors: | Céline Gérard, Jean-Michel Foidart |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2023-05-01
|
Series: | Drugs in R&D |
Online Access: | https://doi.org/10.1007/s40268-023-00419-5 |
Similar Items
-
Comparison of Estetrol Exposure between Women and Mice to Model Preclinical Experiments and Anticipate Human Treatment
by: Anne Gallez, et al.
Published: (2023-06-01) -
The benefits of estetrol addition to drospirenone for contraception
by: Jean Michel Foidart, PhD, MD, et al.
Published: (2023-11-01) -
Estetrol Combined to Progestogen for Menopause or Contraception Indication Is Neutral on Breast Cancer
by: Anne Gallez, et al.
Published: (2021-05-01) -
The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activation
by: Anne Abot, et al.
Published: (2014-10-01) -
Estetrol Is Safe and Well Tolerated during Treatment of Hospitalized Men and Women with Moderate COVID-19 in a Randomized, Double-Blind Study
by: Jean Michel Foidart, et al.
Published: (2023-06-01)